Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

android tablet pc

Home > Press > BioSquare, the biotechnologies business event Lyon, France

BioSquare, the international business convention, will bring key players from the pharmaceutical and biotechnology industries together in Lyon from 9 - 11 March. The ninth BioSquare convention will be held at the Lyon Congress Center, providing the ideal opportunity to analyze and discuss trends and developments in the sector.

BioSquare, the biotechnologies business event Lyon, France

Lyon, France | Posted on February 26th, 2009

One-to-one meetings, workshops, panels… hundreds of opportunities
Above all, BioSquare provides the opportunity to meet a broad cross-section of fellow biotechnology professionals by means of one-to-one business meetings and company presentations.
Once again, in 2009 business leaders and executives from biotechnology firms, professors, eminent members of business networks, and professionals from innovative industries will meet together and develop scientific, industrial and financial exchanges around new breakthroughs and developments in their sector.

Thanks to, these meetings can be set up prior to the start of the convention. This software, a comprehensive database of stakeholders in the European and North American biotechnology sector, has been used at major industry events the world over including in London, California and Vancouver. Developed to meet the specific requirements of biotechnology companies, this tool is available to participants from the moment they register. It allows them to enter in direct contact with other participants corresponding to their areas of interest and expectations. This makes it possible to optimize the time spent at the BioSquare convention.

The experts discuss and debate
As an extension to the individual meetings and in order to widen the debate, six workshops and two panels will be organized during BioSquare 2009. Experienced participants will analyze the changes and trends in the sector and the strategies to adopt in order to meet the technological, economic and financial challenges facing biotechnology industries today. In line with the attitudes of the contributing speakers and moderators, all professionals involved in the day-to-day activities of the biotechnologies industry, these debates aim to be useful, constructive and solutions-focused.

These eight events include:

* The Brain Device Interface - Monday 9 March, 16:00 - 17:30
This panel aims to map out the medium-term opportunities and issues concerning the three ways in which the brain / device interaction can be used in human health services and treatment:

- By direct contact, with matter exchange, in the field of drug delivery.
- By direct contact with information or energy exchange, with applications in the treatment of neurodegenerative diseases or in implants to treat sight impairments.
- By indirect contact, with information or energy exchange, with an application in magnetoencephalography (MEG) brain activity imaging, for example.

The participants in this session will present the latest innovations in brain / device interfaces and will discuss the economic opportunities they present.

Pr Alim Louis Benabid, Professor Emeritus, University Joseph Fourier, Grenoble.
Fernand Badano, President, Valtronic Technologies
Jonas Garding, R&D Director, Elekta
Paolo Mangiagalli, Ph.D, Advanced Technology R&D Manager ,BD Medical.

Gilles Rubinstenn, Chief Executive Officer, Fondation Pierre Gilles de Genne

* More R&D investment but no more drugs approved: what's wrong? Monday 9 March, 14:15 - 15:30
This panel will look at the major issues in the pharmaceutical industry today. Research and development budgets are constantly being increased but the number of drugs marketed remains limited. Are the instruments for validation at fault? Are the regulatory authorities too stringent? Have the recent examples of drugs withdrawn from sale following the reporting of adverse effects hindered development?

Richard Seebrook, Development Director, Wellcome Trust
Ludo Lauwers, Vice-President, Janssen Pharmaceutica NV
Daniel Cohen, Cheif Executive Officer, Pharnext
Jean-Michel Alexandre, Former Director, EMEA
Mondher Toumi, President - Founder, Creativ Ceutical

Philippe Pouletty, Director of France Biotech, Founder of Truffle Capital

* The cleantech market in Europe - Monday 9 March, 10:45 - 12:00
Cleantechs and biotechs are based on the same technology and use identical tools. Could this common ground lead to synergy or, conversely, competition in obtaining funding for example? The speakers at this workshop will debate on the positioning of these two markets and how to make the most of this synergy.

François Houssin, Development Manager, European Listing, NYSE Euronext
Peter Rosholm, Vice-President, Novozymes
Dr Richard J. LaDuca, Development Director, Genencor

Albin Jourda, Managing director, Gallium Moore

For the full program of panels and workshops:
Consult the list of speakers to date:

Lyon, the Life Sciences capital
From 9 - 11 March 2009 Lyon will be the undisputed capital of the Life Sciences world as it will host both the BioSquare international biotechnologies business convention and BioVision, the World Life Sciences Forum. Holding these events simultaneously offers participants the opportunity to understand the stakes and the concrete applications of Life Sciences. Three thousand participants from the world over are expected to attend BioVision which will tackle the major theme of the role of Life Sciences in meeting the challenges of urban expansion and devote time to the latest breakthroughs in the Life Sciences field.


For more information, please click here

Virginie Palpacuer
Tel: +33 (0)4 72 00 35 36

Juliette Bastin
Tel: +33 (0)4 72 00 46 86

Nathalie Cayuela
Tel: +33 (0)4 72 00 35 85

Copyright © BioSquare

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Graphene chips are close to significant commercialization October 1st, 2014

Production of Filters for Separation of Water from Petroleum Products in Iran October 1st, 2014

Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014

Speed at its limits September 30th, 2014


Graphene chips are close to significant commercialization October 1st, 2014

Production of Filters for Separation of Water from Petroleum Products in Iran October 1st, 2014

New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014

Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014


Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014

Oxford Instruments launches 3rd annual Indian nanotechnology seminars in Kolkata and Delhi - sharing expertise with Nanotechnology researchers in India September 25th, 2014

Grenoble Hosting SEMICON Europa Oct. 7-9, First Time Event Held in France: Leti’s 90-square-meter Booth Will Feature Portable Showroom To Demonstrate New Technology Innovations September 24th, 2014

Contributing to the spirit of the IYCR 2014 September 24th, 2014


Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

How things coil: Researchers discover that simulation technology designed for Hollywood can be used as a predictive tool for understanding fundamental engineering problems September 29th, 2014

Penn Team Studies Nanocrystals by Passing Them Through Tiny Pores September 26th, 2014

New NIH/DOE Grant for Life Science Studies at NSLS-II: Funding will support operation of three powerful experimental stations designed to reveal detailed structures of proteins, viruses, and more September 23rd, 2014

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE